documents: FDA-2000-N-0108-0016
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2000-N-0108-0016 | FDA | FDA-2000-N-0108 | Tab B - "OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 175-277) | Supporting & Related Material | REF-Reference (internal unless indicated) | 2003-11-03T05:00:00Z | 2003 | 11 | 2010-02-26T21:19:39Z | 0 | 0 | 09000064804c2961 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref